176 related articles for article (PubMed ID: 29525987)
1. An In Vitro System to Study the Mesenchymal-to-Amoeboid Transition.
Chikina AS; Alexandrova AY
Methods Mol Biol; 2018; 1749():21-27. PubMed ID: 29525987
[TBL] [Abstract][Full Text] [Related]
2. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.
Alexandrova AY; Chikina AS; Svitkina TM
Int Rev Cell Mol Biol; 2020; 356():197-256. PubMed ID: 33066874
[TBL] [Abstract][Full Text] [Related]
3. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
[TBL] [Abstract][Full Text] [Related]
4. X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility.
Fujita M; Otsuka Y; Yamada S; Iwakawa M; Imai T
Cancer Sci; 2011 Apr; 102(4):792-8. PubMed ID: 21214671
[TBL] [Abstract][Full Text] [Related]
5. PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness.
Vaškovičová K; Szabadosová E; Čermák V; Gandalovičová A; Kasalová L; Rösel D; Brábek J
BMC Cancer; 2015 Apr; 15():326. PubMed ID: 25924946
[TBL] [Abstract][Full Text] [Related]
6. Amoeboid-mesenchymal migration plasticity promotes invasion only in complex heterogeneous microenvironments.
Talkenberger K; Cavalcanti-Adam EA; Voss-Böhme A; Deutsch A
Sci Rep; 2017 Aug; 7(1):9237. PubMed ID: 28835679
[TBL] [Abstract][Full Text] [Related]
7. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition.
Holle AW; Govindan Kutty Devi N; Clar K; Fan A; Saif T; Kemkemer R; Spatz JP
Nano Lett; 2019 Apr; 19(4):2280-2290. PubMed ID: 30775927
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of motility in metastasizing cells.
Yilmaz M; Christofori G
Mol Cancer Res; 2010 May; 8(5):629-42. PubMed ID: 20460404
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of tumor cell migration strategy and the migration transition mechanism].
Wang H; Tan Q; Yang BY; Zou X; Yang L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1251-6. PubMed ID: 22295724
[TBL] [Abstract][Full Text] [Related]
11. Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells.
Liu YJ; Le Berre M; Lautenschlaeger F; Maiuri P; Callan-Jones A; Heuzé M; Takaki T; Voituriez R; Piel M
Cell; 2015 Feb; 160(4):659-672. PubMed ID: 25679760
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
Belgiovine C; Frapolli R; Bonezzi K; Chiodi I; Favero F; Mello-Grand M; Dei Tos AP; Giulotto E; Taraboletti G; D'Incalci M; Mondello C
PLoS One; 2010 Nov; 5(11):e14154. PubMed ID: 21209796
[TBL] [Abstract][Full Text] [Related]
14. A flexible network of vimentin intermediate filaments promotes migration of amoeboid cancer cells through confined environments.
Lavenus SB; Tudor SM; Ullo MF; Vosatka KW; Logue JS
J Biol Chem; 2020 May; 295(19):6700-6709. PubMed ID: 32234762
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells.
Panková K; Rösel D; Novotný M; Brábek J
Cell Mol Life Sci; 2010 Jan; 67(1):63-71. PubMed ID: 19707854
[TBL] [Abstract][Full Text] [Related]
16. FilGAP, a Rho/Rho-associated protein kinase-regulated GTPase-activating protein for Rac, controls tumor cell migration.
Saito K; Ozawa Y; Hibino K; Ohta Y
Mol Biol Cell; 2012 Dec; 23(24):4739-50. PubMed ID: 23097497
[TBL] [Abstract][Full Text] [Related]
17. Localized translation regulates cell adhesion and transendothelial migration.
Bergeman J; Caillier A; Houle F; Gagné LM; Huot MÉ
J Cell Sci; 2016 Nov; 129(21):4105-4117. PubMed ID: 27637266
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.
Taddei ML; Giannoni E; Morandi A; Ippolito L; Ramazzotti M; Callari M; Gandellini P; Chiarugi P
Cell Commun Signal; 2014 Apr; 12():24. PubMed ID: 24690323
[TBL] [Abstract][Full Text] [Related]
19. Morphological Analysis of Amoeboid-Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer Cells.
Facoetti A; DI Gioia C; Pasi F; DI Liberto R; Corbella F; Nano R; Ciocca M; Valvo F; Orecchia R
Anticancer Res; 2018 Aug; 38(8):4585-4591. PubMed ID: 30061225
[TBL] [Abstract][Full Text] [Related]
20. Apolar and polar transitions drive the conversion between amoeboid and mesenchymal shapes in melanoma cells.
Cooper S; Sadok A; Bousgouni V; Bakal C
Mol Biol Cell; 2015 Nov; 26(22):4163-70. PubMed ID: 26310441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
